Alirocumab treatment and neurocognitive function according to the CANTAB scale in patients at increased cardiovascular risk: A prospective, randomized, placebo-controlled study
Janik, Matthew J., Urbach, Dorothea V., van Nieuwenhuizen, Elane, Zhao, Jian, Yellin, Ori, Baccara-Dinet, Marie T., Pordy, Robert, Manvelian, Garen
Published in Atherosclerosis (01.08.2021)
Published in Atherosclerosis (01.08.2021)
Get full text
Journal Article